LTGO

NASD Latigo Biotherapeutics, Inc.

Oct 26, 2026 · 8:10 AM ET LAST TRADE Market Closed

$15.50 ↑ +0.48 (+3.20%) Trading Up from the previous close of $15.02

YTD change: -15.07%
vs 20-day SMA: -1.91%
vs 200-day SMA: N/A

Price ranges

Previous day

$14.84 $16.55

open $16.51 close $15.02

-$1.49 (-9.02%)

Today

$0.00 $0.00

$15.50

Past week

$13.54 $17.67

from $14.00 now $15.50

+$1.50 (+10.71%)

Past month

$13.50 $18.50

from $17.15 now $15.50

-$1.65 (-9.62%)

This year

$13.50 $25.93

from $18.25 now $15.50

-$2.75 (-15.07%)

Price & Performance

-3.23 (-17.70%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 40.2% away from all-time highs of $25.93
LTGO is down 15% since the beginning of the year
LTGO is down 15% over the past 12 months
LTGO is down 10% over the past 1 month
3% of all LTGO investors are betting against LTGO

LTGO reads not so good: the 12-month move is -17.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.4564

Earnings momentum +27.1% Quarterly EPS growth

Quarterly change +27.1%

Valuation

P/E ratio N/A

Enterprise value $1.3B

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$55.2M

Debt$31.2K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $1.0B

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded by Bryan Moyer on November 20, 2018 and is headquartered in Thousand Oaks, CA.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,273.46	-2.54%
JNJ	Johnson & Johnson	$263.81	-1.42%
ABBV	AbbVie, Inc.	$285.64	+0.16%
MRK	Merck & Co., Inc.	$145.27	-1.34%
RHHBY	Roche Holding Ltd Sponsored ADR	$61.17	+2.60%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.